Ontario Securities Commission

Amcomri Applies for Management Cease Trade Order

Retrieved on: 
Tuesday, March 19, 2024

The Annual Filings are required to be filed on or before April 2, 2024.

Key Points: 
  • The Annual Filings are required to be filed on or before April 2, 2024.
  • The Company’s auditor requires more time to complete its customary quality reviews with respect to significant risk areas for purposes of the Annual Filings.
  • The Company will work closely with its auditor to complete the Annual Filings and expects to file the Annual Filings on or about April 15, 2024.
  • If an MCTO is granted, the Company's directors and senior officers and other insiders will not be able to trade the Company's securities while the MCTO is in effect.

Li-Cycle Reports Full Year 2023 Results

Retrieved on: 
Friday, March 15, 2024

The change resulted in a transition period of November 1, 2022 through December 31, 2022.

Key Points: 
  • The change resulted in a transition period of November 1, 2022 through December 31, 2022.
  • The Company has calculated the income statement for the year ended December 31, 2022 and has provided a comparison to the year ended December 31, 2023 below.
  • As of December 31, 2023, Li-Cycle had cash and cash equivalents on hand of $70.6 million.
  • Li-Cycle anticipates filing the Restated Interim Financial Reports and related MD&As on or before April 29, 2024.

Li-Cycle Announces $75 Million Strategic Investment from Glencore

Retrieved on: 
Tuesday, March 12, 2024

Ajay Kochhar, Li-Cycle co-founder and CEO, commented: “We are pleased to secure an additional $75 million investment from Glencore, following Glencore’s June 2022 investment, to improve our liquidity position while we continue our ongoing comprehensive review process.

Key Points: 
  • Ajay Kochhar, Li-Cycle co-founder and CEO, commented: “We are pleased to secure an additional $75 million investment from Glencore, following Glencore’s June 2022 investment, to improve our liquidity position while we continue our ongoing comprehensive review process.
  • The SC engaged Moelis & Company LLC, a leading global investment bank (“Moelis”), as its financial advisor and placement agent.
  • As part of the partnership, Glencore previously made a $200 million investment in Li-Cycle in June 2022 through the purchase of a convertible note (the “Existing Note”).
  • The Glencore investment will result in Glencore purchasing from the Company a senior secured convertible note in the aggregate principal amount of $75 million.

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Retrieved on: 
Friday, April 5, 2024

Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

Key Points: 
  • Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
  • Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
  • The Company anticipates filing the Required Annual Filings by April 30, 2024.
  • In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

OSC investor warnings and alerts for March 12-April 2, 2024

Retrieved on: 
Tuesday, April 2, 2024

TORONTO, April 2, 2024 /CNW/ - The Ontario Securities Commission (OSC) is warning Ontario investors that the following companies are not registered to deal or advise in securities in Ontario:

Key Points: 

TORONTO, April 2, 2024 /CNW/ - The Ontario Securities Commission (OSC) is warning Ontario investors that the following companies are not registered to deal or advise in securities in Ontario:

Payfare Announces Delay in its Annual Filings

Retrieved on: 
Thursday, March 28, 2024

As a result, the Company will also be required to delay filing of its Annual Information Form for the year ended December 31, 2023 (the "AIF").

Key Points: 
  • As a result, the Company will also be required to delay filing of its Annual Information Form for the year ended December 31, 2023 (the "AIF").
  • The Company has the necessary financial and human resources to remedy the default and expects to remedy the default by filing the Annual Filings by April 12, 2024 and will issue a news release announcing completion of filing of the Annual Filings at such time as they are completed and filed.
  • Upon filing its Annual Filings, the Company will also file its AIF.
  • The delay in the Annual Filings is due solely to the delay in receiving the SOC 1 report from a vendor.

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Retrieved on: 
Thursday, March 21, 2024

Under National Instrument 51-102, the Required Annual Filings were required to be made not later than February 28, 2024.

Key Points: 
  • Under National Instrument 51-102, the Required Annual Filings were required to be made not later than February 28, 2024.
  • The Company had expected to file the Required Annual Filings by March 30, 2024, and now anticipates filing the Required Annual Filings by April 30, 2024.
  • Under National Instrument 51-102, the Required Interim Filings are required to be made not later than April 1, 2024.
  • The Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

OSC opens registration for OSC Dialogue 2024

Retrieved on: 
Wednesday, March 20, 2024

TORONTO, March 20, 2024 /CNW/ - The Ontario Securities Commission (OSC) today opened registration for OSC Dialogue 2024: Inviting, thriving and secure capital markets.

Key Points: 
  • TORONTO, March 20, 2024 /CNW/ - The Ontario Securities Commission (OSC) today opened registration for OSC Dialogue 2024: Inviting, thriving and secure capital markets.
  • Cameron Schuler, Chief Commercialization Officer and Vice President, Industry Innovation, Vector Institute
    OSC Dialogue 2024 will take place on Wednesday, May 22, 2024, at the Metro Toronto Convention Centre.
  • For the latest updates on OSC Dialogue, please subscribe to our event updates , visit the OSC website , and follow #OSCDialogue on X and LinkedIn.
  • Investors are urged to check the registration of any persons or company offering an investment opportunity and to review the OSC investor materials available at http://www.osc.ca .

Notice - CAPITAL MARKETS TRIBUNAL ANNOUNCES AMENDMENTS TO ITS RULES OF PROCEDURE

Retrieved on: 
Tuesday, March 19, 2024

TORONTO, March 19, 2024 /CNW/ - On March 19, 2024, the Capital Markets Tribunal implemented substantial amendments to its Rules of Procedure (Rules).

Key Points: 
  • TORONTO, March 19, 2024 /CNW/ - On March 19, 2024, the Capital Markets Tribunal implemented substantial amendments to its Rules of Procedure (Rules).
  • The former Rules of Procedure and Forms and Practice Guideline are repealed in their entirety and replaced by the new Rules, which are effective immediately.
  • The Rules apply to all Tribunal proceedings, including proceedings commenced prior to the issuance of this Notice.
  • In addition, the amendments to the Rules improve readability, clarify requirements, and will improve the efficiency of Tribunal proceedings.

OSC investor warnings and alerts for February 20-March 12, 2024

Retrieved on: 
Tuesday, March 12, 2024

TORONTO, March 12, 2024 /CNW/ - The Ontario Securities Commission (OSC) is warning Ontario investors that the following companies are not registered to deal or advise in securities in Ontario:

Key Points: 

TORONTO, March 12, 2024 /CNW/ - The Ontario Securities Commission (OSC) is warning Ontario investors that the following companies are not registered to deal or advise in securities in Ontario: